Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral Covid-19 Hospital (original) (raw)

Two SARS-CoV-2 IgG Immunoassays Comparison and Time-Course Profile of Antibodies Response

2020

Anti-SARS-CoV-2 IgG and Neutralizing Antibody Levels in Patients with Past COVID-19 Infection: A Longitudinal Study

Balkan Medical Journal

Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients

Tim Plant

2020

View PDFchevron_right

SARS-CoV-2 IgG response in symptomatic and asymptomatic COVID-19-infected healthcare workers

Ezequiel Cordova

Occupational Medicine, 2021

View PDFchevron_right

Clinical significance of early IgA anti‑SARS‑CoV‑2 antibody detection in patients from a Romanian referral COVID‑19 hospital

Carmen Manciuc

Experimental and Therapeutic Medicine

View PDFchevron_right

Comparison of Neutralizing Sars Cov-2 Igg Antibody Levels in Hospitalized Patients at Dr. Mohammad Hoesin Palembang Hospital

Zen Ahmad

Malahayati Nursing Journal

View PDFchevron_right

Investigation of Anti-SARS-CoV-2 IgG and IgM Antibodies in the Patients with COVID-19 by Three Different ELISA Test Kits

Masayuki Nagasawa

SN Comprehensive Clinical Medicine, 2020

View PDFchevron_right

Patients With Several Clinical Presentations By SARS-CoV2 Showed A Dramatic Decrease Of Antibodies

Evelin Garay M.

2021

View PDFchevron_right

Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome

Nelson Lee

Journal of Clinical Virology, 2006

View PDFchevron_right

SARS-COV-2 Neutralizing IgG Antibodies in Patients Recovered from COVID-19 in a Hospital-Based Study: From Predictions to Reality

zen amr

Journal of Rawalpindi Medical College, 2021

View PDFchevron_right

Immunoglobulin G antibody immune response profile following infection with SARS-CoV-2 in COVID-19 Egyptian patients

Nesreen Mohammed

Egyptian journal of Immunology

View PDFchevron_right

Anti-SARS-CoV-2 Antibody Status at the Time of Hospital Admission and the Prognosis of Patients with COVID-19: A Prospective Observational Study

Peter Mihalov

Infectious Disease Reports

View PDFchevron_right

Specific clinical characteristics are correlated with long-term SARS CoV-2 IgG titers

Chen Zamir

Research Square (Research Square), 2022

View PDFchevron_right

Evaluation of IgG Neutralizing Antibodies to SARS-CoV-2 Among Healthcare Workers Who Frequently Encountered COVID-19 Patients in Our Hospital

Hikmet Alışkan

Mediterranean Journal of Infection Microbes and Antimicrobials, 2022

View PDFchevron_right

Laboratory evaluation of SARS-CoV-2 antibodies: detectable IgG up to 20 weeks post infection

Ruth Price

2020

View PDFchevron_right

Persistence of IgG response to SARS-CoV-2

Leo Heyndrickx

The Lancet Infectious Diseases, 2021

View PDFchevron_right

SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19

Bernd Salzberger

Infection, 2021

View PDFchevron_right

Long‐term monitoring of the development and extinction of IgA and IgG responses to SARS‐CoV‐2 infection

Andrei Ivanov, Elena Semenova

Journal of Medical Virology, 2021

View PDFchevron_right

Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2

Xunyan Ye

Frontiers in Immunology, 2021

View PDFchevron_right

Evaluation of ELISA tests for the qualitative determination of IgG, IgM and IgA to SARS-CoV-2

G. Matusali

2020

View PDFchevron_right

The Trend of IgG and IgM Antibodies During 6-Month Period After the Disease Episode in COVID-19 Patients

Ehsan Rezaie

Iranian Journal of Science and Technology, Transactions A: Science

View PDFchevron_right

Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice

Isna Mahmudah

2020

View PDFchevron_right

SARS-CoV-2 infections and antibody responses among health care workers in a Spanish hospital after a month of follow-up

Angeline Cruz

medRxiv, 2020

View PDFchevron_right

Prevalence of IgG and IgM antibodies to SARS-CoV-2 among clinic staff and patients

Ubong Udoh

2020

View PDFchevron_right

Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study

Fares Bahrami

International Immunopharmacology, 2021

View PDFchevron_right

Evaluation of the IgG antibody response to SARS CoV-2 infection and performance of a lateral flow immunoassay: cross-sectional and longitudinal analysis over 11 months

Andrew Nesbit

BMJ Open, 2021

View PDFchevron_right

The reliability of SARS-CoV-2 IgG antibody testing – a pilot study in asymptomatic health care workers in a Croatian university hospital

Dragana Šegulja

Croatian Medical Journal, 2020

View PDFchevron_right

Combined Analysis of Anti SARS-CoV-2 IgG and IgM Responses in COVID19 Patients in India

Dr.Deepy Zohmangaihi

Indian Journal of Clinical Biochemistry

View PDFchevron_right

Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral Covid-19 Hospital (original) (raw)

Related papers